The first results of neoadjuvant therapy with the biosimilar of trastuzumab in HER2+ breast cancer stage II-III in routine Russian practice
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI